News Summary

Beautinelle has announced the launch of the BeneLift Pro, an FDA-approved nano infusion device designed to revolutionize professional spa and aesthetics treatments. The device offers a non-invasive, painless treatment with no downtime, aimed at increasing revenue for medical spas and aesthetics clinics. BeneLift Pro features the world’s first FDA-approved CellBorn stem cell solution, enhancing its appeal as a cutting-edge treatment option. Developed with advanced Korean engineering and clinical endorsement, the device is positioned to become the new gold standard in aesthetic treatments.